U.S. markets closed
  • S&P 500

    3,638.35
    +8.70 (+0.24%)
     
  • Dow 30

    29,910.37
    +37.87 (+0.13%)
     
  • Nasdaq

    12,205.85
    +111.45 (+0.92%)
     
  • Russell 2000

    1,855.27
    +10.25 (+0.56%)
     
  • Crude Oil

    45.52
    -0.01 (-0.02%)
     
  • Gold

    1,790.70
    +2.60 (+0.15%)
     
  • Silver

    22.77
    +0.14 (+0.60%)
     
  • EUR/USD

    1.1963
    +0.0050 (+0.42%)
     
  • 10-Yr Bond

    0.8420
    -0.0360 (-4.10%)
     
  • GBP/USD

    1.3334
    -0.0022 (-0.17%)
     
  • USD/JPY

    103.9700
    -0.2800 (-0.27%)
     
  • BTC-USD

    18,262.19
    +494.13 (+2.78%)
     
  • CMC Crypto 200

    333.27
    -4.23 (-1.25%)
     
  • FTSE 100

    6,367.58
    +4.65 (+0.07%)
     
  • Nikkei 225

    26,644.71
    +107.41 (+0.40%)
     

Adaptive Biotechnologies: 3Q Earnings Snapshot

·1 min read

SEATTLE (AP) _ Adaptive Biotechnologies Corp. (ADPT) on Tuesday reported a loss of $36.7 million in its third quarter.

On a per-share basis, the Seattle-based company said it had a loss of 27 cents.

The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 28 cents per share.

The life-sciences research company posted revenue of $26.3 million in the period, also exceeding Street forecasts. Three analysts surveyed by Zacks expected $23.4 million.

Adaptive Biotechnologies shares have climbed 57% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $47.02, a rise of 66% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADPT at https://www.zacks.com/ap/ADPT